Cargando...
Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a barrier to wider realisation of the pot...
Guardado en:
| Publicado en: | Methods Protoc |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564709/ https://ncbi.nlm.nih.gov/pubmed/32784848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/mps3030057 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|